Abstract

To determine the prevalence and clinical characteristics of absolute insulin deficiency in long-standing Type 2 diabetes, using a strategy based on home urinary C-peptide creatinine ratio measurement. We assessed the urinary C-peptide creatinine ratios, from urine samples taken at home 2h after the largest meal of the day, in 191 insulin-treated subjects with Type 2 diabetes (diagnosis age ≥45years, no insulin in the first year). If the initial urinary C-peptide creatinine ratio was ≤0.2nmol/mmol (representing absolute insulin deficiency), the assessment was repeated. A standardized mixed-meal tolerance test with 90-min stimulated serum C-peptide measurement was performed in nine subjects with a urinary C-peptide creatinine ratio ≤ 0.2nmol/mmol (and in nine controls with a urinary C-peptide creatinine ratio >0.2nmol/mmol) to confirm absolute insulin deficiency. A total of 2.7% of participants had absolute insulin deficiency confirmed by a mixed-meal tolerance test. They were identified initially using urinary C-peptide creatinine ratio: 11/191 subjects (5.8%) had two consistent urinary C-peptide creatinine ratios ≤ 0.2nmol/mmol; 9 of these 11 subjects completed a mixed-meal tolerance test and had a median stimulated serum C-peptide of 0.18nmol/l. Five of these 9 had stimulated serum C-peptide <0.2nmol/l and 9/9 subjects with urinary C-peptide creatinine ratio >0.2 had endogenous insulin secretion confirmed by the mixed-meal tolerance test. Compared with subjects with a urinary C-peptide creatinine ratio >0.2nmol/mmol, those with confirmed absolute insulin deficiency had a shorter time to insulin treatment (median 2.5 vs. 6years, P=0.005) and lower BMI (25.1 vs. 29.1kg/m(2) , P=0.04). Two out of the five patients with absolute insulin deficiency were glutamic acid decarboxylase autoantibody-positive. Absolute insulin deficiency may occur in long-standing Type 2 diabetes, and cannot be reliably predicted by clinical features or autoantibodies. Absolute insulin deficiency in Type 2 diabetes may increase the risk of hypoglycaemia and ketoacidosis, as in Type 1 diabetes. Its recognition should help guide treatment, education and management. The urinary C-peptide creatinine ratio is a practical non-invasive method to aid detection of absolute insulin deficiency, with a urinary C-peptide creatinine ratio > 0.2nmol/mmol being a reliable indicator of retained endogenous insulin secretion.

Highlights

  • Most older patients with diabetes have Type 2 diabetes, which is typically a disease where endogenous insulin persists

  • They were identified initially using urinary C-peptide creatinine ratio: 11/191 subjects (5.8%) had two consistent urinary C-peptide creatinine ratios ≤ 0.2 nmol/mmol; 9 of these 11 subjects completed a mixed-meal tolerance test and had a median stimulated serum C-peptide of 0.18 nmol/l. Five of these 9 had stimulated serum C-peptide 0.2 had endogenous insulin secretion confirmed by the mixed-meal tolerance test

  • Compared with subjects with a urinary C-peptide creatinine ratio >0.2 nmol/mmol, those with confirmed absolute insulin deficiency had a shorter time to insulin treatment and lower BMI (25.1 vs. 29.1 kg/m2, P=0.04)

Read more

Summary

Introduction

Most older patients with diabetes have Type 2 diabetes, which is typically a disease where endogenous insulin persists. Progressive b-cell dysfunction occurs in Type 2 diabetes [1,2,3,4], but it is unclear if this leads to absolute insulin deficiency. In Type 1 diabetes absolute insulin deficiency is usual outside the initial ‘honeymoon period’, the period soon after diagnosis when some residual b-cell function may persist [5]. Some patients may present clinically later in life as having Type 2 diabetes, but have the autoimmune destructive process as seen in Type 1 diabetes. These patients can be recognised by pancreatic autoantibodies, known as latent autoimmune diabetes of adulthood (LADA) [6]. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call